A novel mechanism for hypofibrinolysis in diabetes: The role of complement C3

Diabetologia

Volumn 55, Issue 4, 2012, Pages 1103-1113

  Hess, K ^a,b   Alzahrani, S H ^a   Mathai, M ^c   Schroeder, V ^a   Carter, A M ^a   Howell, G ^a   Koko, T ^a   Strachan, M W J ^d   Price, J F ^e   Smith, K A ^a   Grant, P J ^a   Ajjan, R A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c BRADFORD ROYAL INFIRMARY   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Clot structure; Complement C3; Fibrinolysis; Type 1 diabetes

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; FIBRIN; FIBRINOGEN; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FIBRIN CLOT; FIBRIN FORMATION; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOFIBRINOLYSIS; IMMUNOBLOTTING; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SURFACE PLASMON RESONANCE; TURBIDIMETRY; TURBIDITY;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; COMPLEMENT C3; DIABETES MELLITUS, TYPE 1; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HUMANS; MALE;

EID: 84859995395     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2301-7     Document Type: Article

References (39)

1. Berry C, Tardif JC, Bourassa MG (2007) Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 49:631-642
2. Fatah K, Silveira A, Tornvall P, Karpe F, Blomback M, Hamsten A (1996) Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 76:535-540
3. Undas A, Podolec P, Zawilska K et al (2009) Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. Stroke 40:1499-1501
4. Collet JP, Park D, Lesty C et al (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20:1354-1361
5. Collet JP, Allali Y, Lesty C et al (2006) Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 26:2567-2573
6. Ajjan R, Lim BC, Standeven KF et al (2008) Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood 111:643-650
7. Jörneskog G, Egberg N, Fagrell B et al (1996) Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia 39:1519-1523
8. Targher G, Chonchol M, Zoppini G, Franchini M (2011) Hemostatic disorders in type 1 diabetes mellitus. Semin Thromb Hemost 37:58-65
9. Jörneskog G, Hansson LO, Wallen NH, Yngen M, Blombäck M (2003) Increased plasma fibrin gel porosity in patients with type I diabetes during continuous subcutaneous insulin infusion. J Thromb Haemost 1:1195-1201
10. Pieters M, Covic N, du Loots T et al (2006) The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects. Thromb Haemost 96:623-629
11. Ridker PM, Silvertown JD (2008) Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 79:1544-1551
12. Ajjan R, Grant PJ, Futers TS et al (2005) Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thromb Haemost 94:1048-1053
13. Amara U, Flierl MA, Rittirsch D et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185:5628-5636
14. Tedesco F, Fischetti F, Pausa M, Dobrina A, Sim RB, Daha MR (1999) Complement-endothelial cell interactions: pathophysiolog-ical implications. Mol Immunol 36:261-268
15. Shats-Tseytlina EA, Nair CH, Dhall DP (1994) Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis? Blood Coagul Fibrinolysis 5:529-535
16. Distelmaier K, Adlbrecht C, Jakowitsch J et al (2009) Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 102:564-572
17. Schroeder V, Carter AM, Dunne J, Mansfield MW, Grant PJ (2010) Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with type 2 diabetes. J Thromb Haemost 8:2080-2082
18. Muscari A, Massarelli G, Bastagli L et al (2000) Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 21:1081-1090
19. Engström G, Hedblad B, Janzon L, Lindgärde F (2007) Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil 14:392-397
20. Carter AM, Prasad UK, Grant PJ (2009) Complement C3 and C-reactive protein in male survivors of myocardial infarction. Atherosclerosis 203:538-543
21. Clauss A (1957) Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 17:237-246
22. Carter AM, Cymbalista CM, Spector TD, Grant PJ, EuroCLOT Investigators (2007) Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 27:2783-2789
23. Van den Berg CW, van Dijk H, Capel PJ (1989) Rapid isolation and characterization of native mouse complement components C3 and C5. J Immunol Methods 122:73-78
24. Deutsch DG, Mertz ET (1970) Plasminogen: purification from human plasma by affinity chromatography. Science 170:1095-1096
25. Smith KA, Adamson PJ, Pease RJ et al (2011) Interactions between factor XIII and the {alpha}C region of fibrinogen. Blood 117:3460-3468
26. Bobbink IW, Tekelenburg WL, Sixma JJ, de Boer HC, Banga JD, de Groot PG (1997) Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation. Biochem Biophys Res Commun 240:595-601
27. Heliövaara MK, Teppo AM, Karonen SL, Tuominen JA, Ebeling P (2006) Improved glycaemia in type 1 diabetes results in decreased levels of soluble adhesion molecules with no change in serum adiponectin or most acute phase proteins. Exp Clin Endocrinol Diabetes 114:295-300
28. Morimoto Y, Taniguchi H, Yamashiro Y, Ejiri K, Baba S, Arimoto Y (1988) Complements in diabetes mellitus: activation of complement system evidenced by C3d elevation in IDDM. Diabetes Res Clin Pract 5:309-312
29. Sundsmo JS, Papin RA, Wood L et al (1985) Complement activation in type 1 human diabetes. Clin Immunol Immunopathol 35:211-225
30. Charlesworth JA, Timmermans V, Golding J et al (1987) The complement system in type 1 (insulin-dependent) diabetes. Diabetologia 30:372-379
31. Cannon CP (2008) Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol 102:5L-9L
32. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070
33. Henschen-Edman AH (2001) Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease. Ann N Y Acad Sci 936:580-593
34. Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN (2010) Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 33:1529-1535
35. Ajjan RA, Robinson EJ, Alzahrani SH, Grant PJ, Heller SR (2010) The effect of hypoglycemia on fibrin clot structure and fibrinolysis in individuals with type 1 diabetes. Diabetes 59 (Suppl 1):402-PP (Abstract)
36. Grant PJ (2007) Diabetes mellitus as a prothrombotic condition. J Intern Med 262:157-172
37. Medved L, Nieuwenhuizen W (2003) Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost 89:409-419
38. Seya T, Nagasawa S, Matsukura M, Hasegawa H, Atkinson JP (1985) Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis. Complement 2:165-174
39. Tsurupa G, Yakovlev S, McKee P, Medved L (2010) Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin- binding sites. Biochemistry 49:7643-7651